Chai Discovery | $70,000,000 | (Aug 7, 2025)
Xovian Aerospace | $2,500,000 | (Aug 7, 2025)
Elion | $9,300,000 | (Aug 7, 2025)
Certified by Founder
Lodge
ARTBIO
start up
United States
- Cambridge, Massachusetts
- 08/12/2023
- Series A
- $90,000,000
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.
- Industry Biotechnology Research
- Website https://artbio.com/
- LinkedIn https://www.linkedin.com/company/artbio-inc/
Related People
Emanuele OstuniFounder
Switzerland -
Reinach, Basel-Country
Specialties: Commercial execution, Strategy, M&A, Business Development, Entrepreneurship,
August | $7,000,000 | (Aug 7, 2025)
Stavtar Solutions | $55,000,000 | (Aug 7, 2025)
Tavily | $25,000,000 | (Aug 7, 2025)
Clay | $100,000,000 | (Aug 7, 2025)
Tracelight | $3,600,000 | (Aug 7, 2025)
CodeKarma | $2,500,000 | (Aug 7, 2025)
WiseBee | $2,444,263 | (Aug 7, 2025)
Positive Development | $51,500,000 | (Aug 7, 2025)
Vendict | $10,000,000 | (Aug 6, 2025)